SCHEMBL9941023

SCHEMBL9941023

Cc1ccc(S(=O)(=O)n2ccc3cnccc32)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 4/20 0.71
L3MBTL1 Q9Y468 4/20 0.55
HTR6 P50406 7/20 0.48
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
HTT P42858 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15598508 0.88 RAPGEF4 (0.71) RAPGEF4L3MBTL1HTR6HDAC3HDAC4
SCHEMBL30461633 0.88 RAPGEF4 (0.71) RAPGEF4L3MBTL1HTR6HDAC3HDAC4
SCHEMBL2672867 0.85 HTR6 (0.66) RAPGEF4L3MBTL1HTR6HTTMEN1
SCHEMBL15175729 0.83 RAPGEF4 (1.00) RAPGEF4HTR6HDAC3HDAC4HDAC1
SCHEMBL29414854 0.78 HTR6 (0.75) RAPGEF4L3MBTL1HTR6HTTMEN1
SCHEMBL1673252 0.78 HTR6 (0.75) RAPGEF4L3MBTL1HTR6HTTMEN1
SCHEMBL1894102 0.78 HTR6 (0.61) RAPGEF4L3MBTL1HTR6HDAC1HDAC6
SCHEMBL24670231 0.78 RAPGEF4 (0.60) RAPGEF4HTR6HDAC3HDAC4HDAC1
SCHEMBL1203289 0.77 HTR6 (0.73) RAPGEF4L3MBTL1HTR6HTTMEN1
SCHEMBL20302676 0.76 L3MBTL1 (0.51) RAPGEF4L3MBTL1HTR6HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9896459-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IE) 2018-02-20 US disclosed
US-9896459-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IE) 2018-02-20 US disclosed
US-9896459-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IE) 2018-02-20 US disclosed
EP-2651936-B1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN SCIENCES IRELAND UC (IE) 2017-02-22 EP disclosed
CN-103384672-B The substituted piperazine of N-pteridine and piperazine pteridinone 武田药品工业株式会社 2016-09-28 CN disclosed
US-20160251377-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN SCIENCES IRELAND UC (IE) 2016-09-01 US disclosed
US-20160251377-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN SCIENCES IRELAND UC (IE) 2016-09-01 US disclosed
US-20160251377-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN SCIENCES IRELAND UC (IE) 2016-09-01 US disclosed
US-9339494-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IR) 2016-05-17 US disclosed
US-9339494-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IR) 2016-05-17 US disclosed
US-9051317-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IE) 2015-06-09 US disclosed
US-9051317-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IE) 2015-06-09 US disclosed
US-9051317-B2 Azaindoles as respiratory syncytial virus antiviral agents JANSSEN SCIENCES IRELAND UC (IE) 2015-06-09 US disclosed
WO-2014111871-A1 4,5-DIHYDROISOXAZOLE DERIVATIVES AS NAMPT INHIBITORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2014-07-24 WO disclosed
EP-2651936-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS Janssen R&D Ireland (IE) 2013-10-23 EP disclosed
US-20130267556-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN R&D IRELAND (IE) 2013-10-10 US disclosed
US-20130267556-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN R&D IRELAND (IE) 2013-10-10 US disclosed
US-20130267556-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN R&D IRELAND (IE) 2013-10-10 US disclosed
WO-2012080450-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN R&D IRELAND (IE) 2012-06-21 WO disclosed
WO-2012080450-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN R&D IRELAND (IE) 2012-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160251377-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS AZI2, CCNI, ZC3HAV1 RAPGEF4 1894/4885L3MBTL1 4841/4885HTR6 1957/4885
US-20130267556-A1 AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS AZI2, CCNI, ZC3HAV1 RAPGEF4 1894/4885L3MBTL1 4841/4885HTR6 1957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.